Related Experiment Videos
Immunoregulatory changes in Kawasaki disease
1Division of HIV, Sexually Transmitted Diseases, Tuberculosis Laboratory Research,National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, 30333, USA.
Clinical Immunology and Immunopathology
|September 1, 1997
Summary
Kawasaki disease (KD) involves immune system changes, particularly in T-lymphocytes. Treatment with intravenous gamma globulin (IVIG) alters these immune cell markers, suggesting T-cell involvement in KD vasculitis and potential elimination post-treatment.
Area of Science:
- Immunology
- Pediatric Rheumatology
- Vascular Biology
Background:
- Kawasaki disease (KD) is an acute vasculitis affecting young children.
- The etiology of KD remains unknown.
- Intravenous gamma globulin (IVIG) is the standard treatment to prevent cardiac complications.
Purpose of the Study:
- To investigate immune system alterations in KD patients before and after IVIG therapy.
- To examine T-lymphocyte activation, memory, and adhesion markers.
- To compare immune profiles between KD patients and healthy controls.
Main Methods:
- Three-color flow cytometry was used to analyze immune cell populations.
- KD patients were studied pre-IVIG, post-IVIG, and >40 days post-therapy.
- Comparison was made with age-matched pediatric controls and parents.
Main Results:
- Significant decreases in CD19, CD25, CD38, and CD71 positive cells were observed during convalescence compared to pre-IVIG.
- The proportion of CD3(+) T-lymphocytes increased post-treatment.
- Immune marker variability was highest in the patient with cardiac abnormalities.
Conclusions:
- T-lymphocytes play a role in the acute vasculitic process of KD.
- These findings suggest T-lymphocytes involved in endothelial damage are potentially cleared from peripheral blood after IVIG therapy.
- Immune dynamics in KD are complex and warrant further investigation.